Literature DB >> 31637657

Thyroid nodule prevalence among women in areas of high natural background radiation, Karunagappally, Kerala, India.

Ananthakrishnakurup Sreekumar1, Padmavathy Amma Jayalekshmi2,3, Athira Nandakumar4, Raghu Ram K Nair5, Riyaz Ahammed3, Paul Sebastian2, Chihaya Koriyama4, Suminori Akiba4,5, Seiichi Nakamura5, Junji Konishi5.   

Abstract

PURPOSE: Radiation exposure has been reported to cause thyroid nodules. The study area was Karunagapally, which has several areas with high natural radiation levels derived from thorium and its decay products. Since thyroid abnormalities are more common in women, the focus was only on women.
METHODS: The examinations included interview, ultrasonography of the thyroid and serum assays of free thyroxine (FT4), thyrotropin (TSH), and anti-thyroglobulin levels. Cumulative dose during the childhood and lifetime cumulative dose (lagged by 5 years) were estimated.
RESULTS: We examined 524 female residents aged 17-73 years and found 75 cases of solitary solid thyroid nodules. The prevalence of thyroid nodules were 14.1 % (n = 42) in high dose panchayats and 14.5% (n = 33) in low-dose panchayats. In the logistic regression analysis adjusted for age, the prevalence of solitary thyroid nodule was not linearly related to childhood cumulative dose (P for trend = 0.159) and lifetime cumulative dose (P for trend = 0.333). The prevalence of thyroiditis and hypothyroidism was not related to natural radiation exposure. Serum levels of FT4 or TSH were not related to natural radiation exposure.
CONCLUSIONS: The results obtained from the present study do not support the increase of solitary thyroid nodule, thyroiditis or hypothyroidism in relation to high-natural-background-radiation exposure.

Entities:  

Keywords:  Anti-Tg; FT4; High Natural Background Radiation Area; TSH; Thoron; Thyroid nodule

Mesh:

Substances:

Year:  2019        PMID: 31637657     DOI: 10.1007/s12020-019-02071-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  24 in total

1.  ICRP Publication 116. Conversion coefficients for radiological protection quantities for external radiation exposures.

Authors:  N Petoussi-Henss; W E Bolch; K F Eckerman; A Endo; N Hertel; J Hunt; M Pelliccioni; H Schlattl; M Zankl
Journal:  Ann ICRP       Date:  2010 Apr-Oct

2.  Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.

Authors:  Misa Imaizumi; Waka Ohishi; Eiji Nakashima; Nobuko Sera; Kazuo Neriishi; Michiko Yamada; Yoshimi Tatsukawa; Ikuno Takahashi; Saeko Fujiwara; Keizo Sugino; Takao Ando; Toshiro Usa; Atsushi Kawakami; Masazumi Akahoshi; Ayumi Hida
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

3.  Oral cavity cancer risk in relation to tobacco chewing and bidi smoking among men in Karunagappally, Kerala, India: Karunagappally cohort study.

Authors:  Padmavaty Amma Jayalekshmi; Paleth Gangadharan; Suminori Akiba; Chihaya Koriyama; Raghu Ram K Nair
Journal:  Cancer Sci       Date:  2010-12-06       Impact factor: 6.716

4.  Risk of thyroid cancer after exposure to 131I in childhood.

Authors:  Elisabeth Cardis; Ausrele Kesminiene; Victor Ivanov; Irina Malakhova; Yoshisada Shibata; Valeryi Khrouch; Vladimir Drozdovitch; Evaldas Maceika; Irina Zvonova; Oleg Vlassov; André Bouville; Guennadi Goulko; Masaharu Hoshi; Alexander Abrosimov; Jadvyga Anoshko; Larisa Astakhova; Sergey Chekin; Evgenyi Demidchik; Rosaria Galanti; Masahiro Ito; Elena Korobova; Evgenyi Lushnikov; Marat Maksioutov; Vladimir Masyakin; Alexander Nerovnia; Vladimir Parshin; Evgenyi Parshkov; Nikolay Piliptsevich; Aldo Pinchera; Semyon Polyakov; Nina Shabeka; Eero Suonio; Vanessa Tenet; Anatoli Tsyb; Shunichi Yamashita; Dillwyn Williams
Journal:  J Natl Cancer Inst       Date:  2005-05-18       Impact factor: 13.506

5.  American Thyroid Association guidelines for detection of thyroid dysfunction.

Authors:  P W Ladenson; P A Singer; K B Ain; N Bagchi; S T Bigos; E G Levy; S A Smith; G H Daniels; H D Cohen
Journal:  Arch Intern Med       Date:  2000-06-12

6.  Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site.

Authors:  Scott Davis; Kenneth J Kopecky; Thomas E Hamilton; Lynn Onstad
Journal:  JAMA       Date:  2004-12-01       Impact factor: 56.272

7.  A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: dose-response analysis of thyroid follicular adenomas detected during first screening in Ukraine (1998-2000).

Authors:  Lydia B Zablotska; Tetyana I Bogdanova; Elaine Ron; Ovsiy V Epstein; Jacob Robbins; Illya A Likhtarev; Maureen Hatch; Valentyn V Markov; Andre C Bouville; Valery A Olijnyk; Robert J McConnell; Victor M Shpak; Alina Brenner; Galina N Terekhova; Ellen Greenebaum; Valery P Tereshchenko; Daniel J Fink; Aaron B Brill; Galina A Zamotayeva; Ihor J Masnyk; Geoffrey R Howe; Mykola D Tronko
Journal:  Am J Epidemiol       Date:  2007-11-06       Impact factor: 4.897

8.  Thyroid diseases among atomic bomb survivors in Nagasaki.

Authors:  S Nagataki; Y Shibata; S Inoue; N Yokoyama; M Izumi; K Shimaoka
Journal:  JAMA       Date:  1994-08-03       Impact factor: 56.272

9.  Background radiation and cancer incidence in Kerala, India-Karanagappally cohort study.

Authors:  Raghu Ram K Nair; Balakrishnan Rajan; Suminori Akiba; P Jayalekshmi; M Krishnan Nair; P Gangadharan; Taeko Koga; Hiroshige Morishima; Seiichi Nakamura; Tsutomu Sugahara
Journal:  Health Phys       Date:  2009-01       Impact factor: 1.316

10.  Juvenile hypothyroidism among two populations exposed to radioiodine.

Authors:  J R Goldsmith; C M Grossman; W E Morton; R H Nussbaum; E A Kordysh; M R Quastel; R B Sobel; F D Nussbaum
Journal:  Environ Health Perspect       Date:  1999-04       Impact factor: 9.031

View more
  1 in total

Review 1.  Understanding the harm of low-dose computed tomography radiation to the body (Review).

Authors:  Hai-Min Shi; Zhi-Chao Sun; Fang-He Ju
Journal:  Exp Ther Med       Date:  2022-06-23       Impact factor: 2.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.